Rhoen-Klinikum AG
General ticker "RHKJF" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.0B (TTM average)
Rhoen-Klinikum AG does not follow the US Stock Market performance with the rate: nan%.
Estimated limits based on current volatility of 0.0%: low 15.30$, high 15.30$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-29, amount 0.23$ (Y1.50%)
- Earnings for 18 months up through Q2 (+1 year) are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [11.25$, 17.21$]
- 2025-12-31 to 2026-12-31 estimated range: [11.84$, 18.11$]
Financial Metrics affecting the RHKJF estimates:
- Positive: with PPE of 18.7 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 15.58 > 12.98
- Positive: -4.17 < Operating profit margin, % of 3.02
- Negative: Shareholder equity ratio, % of 69.81 > 63.79
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of 2.82 <= 5.54
- Negative: 0 < Inventory ratio change, % of 0.59
- Positive: 1.89 < Return on assets ratio (scaled to [-100,100]) of 2.38
Short-term RHKJF quotes
Long-term RHKJF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €1,734.72MM | €1,595.62MM | €1,934.99MM |
| Operating Expenses | €1,694.33MM | €1,547.47MM | €1,930.60MM |
| Operating Income | €40.40MM | €48.15MM | €4.39MM |
| Non-Operating Income | €7.33MM | €8.05MM | €40.54MM |
| Interest Expense | €3.70MM | €3.40MM | €3.01MM |
| Income(Loss) | €47.73MM | €56.20MM | €44.93MM |
| Taxes | €7.56MM | €11.00MM | €8.66MM |
| Net Income(Loss)* | €38.71MM | €43.35MM | €34.46MM |
| Stockholders Equity | €1,252.04MM | €1,295.93MM | €1,320.13MM |
| Inventory | €34.21MM | €37.46MM | €40.56MM |
| Assets | €1,770.52MM | €1,856.48MM | €1,818.49MM |
| Operating Cash Flow | €109.00MM | €127.60MM | €64.48MM |
| Capital expenditure | €62.80MM | €70.40MM | €99.06MM |
| Investing Cash Flow | €40.90MM | €-50.40MM | €-132.05MM |
| Financing Cash Flow | €-21.20MM | €-3.30MM | €-41.98MM |
| Earnings Per Share** | €0.58 | €0.67 | €0.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.